Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (253)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Repotrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Repotrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Resminostat	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Resminostat Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Revumenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Revumenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Rezivertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Rezivertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Ridaforolimus	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Ridaforolimus Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Ripretinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Ripretinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Rogaratinib	FGFR Inhibitor	Solid Tumour
Molecule Rogaratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Romidepsin	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Romidepsin Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Roniciclib	CDK Inhibitor	Solid Tumour
Molecule Roniciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Rucaparib	PARP Inhibitor	Solid Tumour
Molecule Rucaparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Sapanisertib	mTOR Inhibitor	Both (Solid & Hematologic)
Molecule Sapanisertib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Savolitinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Savolitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor

Repotrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Resminostat Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Revumenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Rezivertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Ridaforolimus Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Ripretinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Rogaratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Romidepsin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Roniciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Rucaparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Sapanisertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism mTOR Inhibitor
Savolitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor

‹ 1 … 14 15 16 17 18 … 22 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (253)

Repotrectinib

Resminostat

Revumenib

Rezivertinib

Ridaforolimus

Ripretinib

Rogaratinib

Romidepsin

Roniciclib

Rucaparib

Sapanisertib

Savolitinib

Repotrectinib

Resminostat

Revumenib

Rezivertinib

Ridaforolimus

Ripretinib

Rogaratinib

Romidepsin

Roniciclib

Rucaparib

Sapanisertib

Savolitinib